Skip to main content

Trilaciclib hydrochloride (C007B-430585)

Catalog No.
C007B-430585
Mfr. No.
T647984-100mg
Mfr. Name
Aladdin Scientific
Qty/UOM
1
UOM
EA
Price: $2,806.25
List Price: $3,118.05

Trilaciclib hydrochloride (G1T28 hydrochloride) is a CDK4/6 inhibitor with IC 50 s of 1 nM and 4 nM for CDK4 and CDK6 , respectivelyIn VitroIncubation with Trilaciclib hydrochloride (G1T28) for 24 hours induces a robust G 1 cell-cycle arrest

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account. Contact Us

Adding to cart… The item has been added
Trilaciclib hydrochloride (G1T28 hydrochloride) is a CDK4/6 inhibitor with IC 50 s of 1 nM and 4 nM for CDK4 and CDK6 , respectivelyIn VitroIncubation with Trilaciclib hydrochloride (G1T28) for 24 hours induces a robust G 1 cell-cycle arrest (time=0). By 16 hours after Trilaciclib hydrochloride washout, cells have reentered the cell cycle and demonstrate cell-cycle kinetics similar to untreated control cells. These results demonstrate that Trilaciclib hydrochloride causes a transient, and reversible G 1 arrest. A transient Trilaciclib hydrochloride-mediated G 1 cell-cycle arrest in CDK4/6-sensitive cells decreases the in vitro toxicity of a variety of commonly used cytotoxic chemotherapy agents associated with myelosuppression. MCE has not independently confirmed the accuracy of these methods. They are for reference only.In VivoTrilaciclib hydrochloride (G1T28) treatment results in a robust and dose-dependent suppression of proliferation in HSPCs at 12 hours, with 5-ethynyl-2′-deoxyuridine (EdU) incorporation returning near baseline levels in a dose-dependent manner by 24 hours after administration. These data demonstrate that a single oral dose of Trilaciclib hydrochloride can produce reversible cell-cycle arrest in HSPCs in a dose-dependent manner in vivo . Mice given 100 mg/kg Trilaciclib hydrochloride 30 minutes prior to etoposide treatment, exhibits only background levels of caspase-3/7 activity. These data demonstrate that Trilaciclib hydrochloride can protect the bone marrow from chemotherapy-induced apoptosis in vivo . The data demonstrate that treatment with Trilaciclib hydrochloride prior to 5-fluorouracil (5-FU) likely decreases 5-FU-induced damage by chemotherapy in HSPCs, thus accelerating blood count recovery after chemotherapy . MCE has not independently confirmed the accuracy of these methods. They are for reference only.Form:SolidIC50& Target:Cdk4/cyclin D1 1 nM (IC 50 ) cdk6/cyclin D3 4 nM (IC 50 ). Specification: 0.99 Molecular Formula: C24H32Cl2N8O Molecular Weight: 519.47
UPC:
51112610
Condition:
New
Availability:
8-12 weeks
Weight:
1.06 Ounces
HazmatClass:
No
WeightUOM:
LB
MPN:
T647984-100mg
CAS:
1977495-97-8
Product Size:
100mg

Cenmed Satisfaction Guarantee
Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.

Testimonial
"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."

LAB DIRECTOR

Testimonial
"We utilized Cenmed's capabilities for a variety of projects around the world. They are a valued partner and supplier."

PHARMACEUTICAL SUPPLY CHAIN LEADER

Testimonial
"The reps are very good at finding products for customers in this period of supply chain issues."

SCOTT BEHMAN

Testimonial
"Your customer service has been excellent and makes me excited about purchasing with Cenmed in the future!!"

PROCUREMENT + BILLING COORDINATOR AT PHARMA.